Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates
Provided By GlobeNewswire
Last update: Nov 13, 2024
- Announced Positive Initial Data, Including Complete and Partial Responses, with IMM-1-104 in Combination with Chemotherapy in First-Line Pancreatic Cancer Patients -
Read more at globenewswire.com
